These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 21811172

  • 1. Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial.
    Tsai CS, Wu CL, Chou SY, Tsang HY, Hung TH, Su JA.
    Int Clin Psychopharmacol; 2011 Sep; 26(5):263-7. PubMed ID: 21811172
    [Abstract] [Full Text] [Related]

  • 2. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 3. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT, Isaac MB, Gallo F, Tournoux A.
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [Abstract] [Full Text] [Related]

  • 4. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME, Palmer RH, Gendreau RM, Wang Y, Clauw DJ.
    Pain Pract; 2011 Dec; 11(2):120-31. PubMed ID: 20642487
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
    Yamakawa Y, Satoh S, Sawa S, Ohta H, Asada T.
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):705-10. PubMed ID: 16401247
    [Abstract] [Full Text] [Related]

  • 6. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
    Rosenberg G, Bornstein N, Diener HC, Gorelick PB, Shuaib A, Lees K, MACSI investigators.
    Int J Stroke; 2011 Aug; 6(4):362-7. PubMed ID: 21645269
    [Abstract] [Full Text] [Related]

  • 7. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial.
    Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ.
    Ann Neurol; 2010 Oct; 68(4):503-10. PubMed ID: 20976769
    [Abstract] [Full Text] [Related]

  • 8. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 9. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 10. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.
    Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S.
    Phytomedicine; 2006 Nov; 13(9-10):607-11. PubMed ID: 16979327
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ, Conesa A, Spanish Milnacipran/Imipramine Study.
    Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
    Sato S, Yamakawa Y, Terashima Y, Ohta H, Asada T.
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942
    [Abstract] [Full Text] [Related]

  • 13. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study.
    Jorge RE, Robinson RG, Tateno A, Narushima K, Acion L, Moser D, Arndt S, Chemerinski E.
    Biol Psychiatry; 2004 Feb 15; 55(4):398-405. PubMed ID: 14960293
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of high dose dexamethasone in the treatment of acute stroke.
    Ogun SA, Odusote KA.
    West Afr J Med; 2001 Feb 15; 20(1):1-6. PubMed ID: 11505880
    [Abstract] [Full Text] [Related]

  • 15. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM.
    Pain Med; 2010 Feb 15; 11(2):180-94. PubMed ID: 20002596
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
    Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG.
    Hum Psychopharmacol; 2004 Oct 15; 19 Suppl 1():S27-35. PubMed ID: 15378666
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of statin use and poststroke depression.
    Kim JM, Stewart R, Kang HJ, Bae KY, Kim SW, Shin IS, Kim JT, Park MS, Cho KH, Yoon JS.
    J Clin Psychopharmacol; 2014 Feb 15; 34(1):72-9. PubMed ID: 24304857
    [Abstract] [Full Text] [Related]

  • 18. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G, Zecca B, Monzani V, Maestroni A, Rossi P, Cazzaniga M, Manganaro D, Boiti C, Zilioli E, Borutti G, Falaschi F, Mandelli C.
    Cerebrovasc Dis; 2010 Feb 15; 29(3):275-81. PubMed ID: 20090319
    [Abstract] [Full Text] [Related]

  • 19. A prospective study of predictors of poststroke depression.
    Carota A, Berney A, Aybek S, Iaria G, Staub F, Ghika-Schmid F, Annable L, Guex P, Bogousslavsky J.
    Neurology; 2005 Feb 08; 64(3):428-33. PubMed ID: 15699370
    [Abstract] [Full Text] [Related]

  • 20. Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).
    Hansen BH, Hanash JA, Rasmussen A, Hansen JF, Andersen NL, Nielsen OW, Birket-Smith M.
    J Psychosom Res; 2012 Jan 08; 72(1):11-6. PubMed ID: 22200516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.